ASB16 and cancer: ASB16-AS1 expression were positively correlated with MSI in 8 cancer types: LUSC (r =0.26, p <0.001), LUAD (r =0.24, p <0.001), UCEC (r =0.22, p <0.001), PRAD (r =0.21, p <0.001), THCA (r =0.15, p =0.001), BLCA (r =0.14, p =0.004), HNSC (r =0.11, p =0.011), BRCA (r =0.07, p =0.018), and negatively correlated with 2 cancer types: DLBC (r =−0.40, p =0.005) and UVM (r =−0.22, p =0.047) (Figure 6c).